Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells

被引:535
|
作者
Castriconi, R
Cantoni, C
Della Chiesa, M
Vitale, M
Marcenaro, E
Conte, R
Biassoni, R
Bottino, C
Moretta, L
Moretta, A
机构
[1] Univ Genoa, Dipartimento Med Sperimentale, I-16132 Genoa, Italy
[2] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[3] Ist Giannina Gaslini, I-16148 Genoa, Italy
[4] Univ Genoa, Ctr Eccellenza Ric Biomed, I-16132 Genoa, Italy
关键词
D O I
10.1073/pnas.0730640100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The surface density of the triggering receptors responsible for the natural killer (NK)-mediated cytotoxicity is crucial for the ability of INK cells to kill susceptible target cells. In this study, we show that transforming growth factor beta1 (TGFbeta1) down-regulates the surface expression of NKp30 and in part of NKG2D but not that of other triggering receptors such as NKp46. The TGFbeta1-mediated inhibition of NKp30 surface expression reflects gene regulation at the transcriptional level. NKp30 has been shown to represent the major receptor involved in the NK-mediated killing of dendritic cells. Accordingly, the TGFbeta1-dependent down-regulation of NKp30 expression profoundly inhibited the NK-mediated killing of dendritic cells. On the contrary, killing of different NK-susceptible tumor cell lines was variably affected, reflecting the differential usage of NKp30 and/or NKG2D in the lysis of such tumors. Our present data suggest a possible mechanism by which TGFbeta1producing dendritic cells may acquire resistance to the NK-mediated attack.
引用
收藏
页码:4120 / 4125
页数:6
相关论文
共 50 条
  • [21] Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells
    Matusali, Giulia
    Tchidjou, Hyppolite Kuekou
    Pontrelli, Giuseppe
    Bernardi, Stefania
    D'Ettorre, Gabriella
    Vullo, Vincenzo
    Buonomini, Anna Rita
    Andreoni, Massimo
    Santoni, Angela
    Cerboni, Cristina
    Doria, Margherita
    FASEB JOURNAL, 2013, 27 (06): : 2440 - 2450
  • [22] Enhancing Natural Killer Cell-Mediated Lysis of Lymphoma Cells By Combining Therapeutic Antibodies with CD20-Specific Immunoligands Engaging NKG2D or NKp30
    Peipp, Matthias
    Kellner, Christian
    Guenther, Andreas
    Humpe, Andreas
    Repp, Roland
    Klausz, Katja
    Derer, Stefanie
    Valerius, Thomas
    van de Winkel, Jan G. J.
    Parren, Paul W. H. I.
    Gramatzki, Martin
    BLOOD, 2014, 124 (21)
  • [23] IL-15 INHIBITS EXPRESSION OF KILLER INHIBITORY NK RECEPTORS AND UPREGULATES EXPRESSION OF NKG2D ON NK AND NKT CELLS IN PROSTATE CANCER-PBMC COCULTURES
    Elhage, Oussama
    Sakellariou, Christina
    Ukimura, Osamu
    Gill, Inderbir
    Smith, Richard Anthony
    Galustian, Christine
    Dasgupta, Prokar
    JOURNAL OF UROLOGY, 2013, 189 (04): : E545 - E545
  • [24] Transforming growth factor-β1 downregulates NKG2D killer activator receptor expression on cytotoxic cells in patients with chronic HCV hepatitis
    Par, G.
    Berki, T.
    Palinkas, L.
    Szereday, L.
    Halasz, M.
    Miseta, A.
    Hegedus, G.
    Faust, Z.
    Mozsik, G.
    Hunyady, B.
    Par, A.
    LIVER INTERNATIONAL, 2006, 26 : 8 - 8
  • [25] Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells
    Vacca, Paola
    Cantoni, Claudia
    Prato, Carola
    Fulcheri, Ezio
    Moretta, Alessandro
    Moretta, Lorenzo
    Mingari, Maria Cristina
    INTERNATIONAL IMMUNOLOGY, 2008, 20 (11) : 1395 - 1405
  • [26] HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing
    Richard, Jonathan
    Sindhu, Sardar
    Pham, Tram N. Q.
    Belzile, Jean-Philippe
    Cohen, Eric A.
    BLOOD, 2010, 115 (07) : 1354 - 1363
  • [27] Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients
    Martinovic, Katarina M. Mirjacic
    Babovic, Nada Lj.
    Dzodic, Radan R.
    Jurisic, Vladimir B.
    Tanic, Nikola T.
    Konjevic, Gordana M.
    MELANOMA RESEARCH, 2014, 24 (04) : 295 - 304
  • [28] Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age
    Carmen Campos
    Nelson López
    Alejandra Pera
    Juan J. Gordillo
    Fakhri Hassouneh
    Raquel Tarazona
    Rafael Solana
    Biogerontology, 2015, 16 : 671 - 683
  • [29] SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D
    Lee, Madeline J.
    Leong, Michelle W.
    Rustagi, Arjun
    Beck, Aimee
    Zeng, Leiping
    Holmes, Susan
    Qi, Lei S.
    Blish, Catherine A.
    CELL REPORTS, 2022, 41 (12):
  • [30] Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age
    Campos, Carmen
    Lopez, Nelson
    Pera, Alejandra
    Gordillo, Juan J.
    Hassouneh, Fakhri
    Tarazona, Raquel
    Solana, Rafael
    BIOGERONTOLOGY, 2015, 16 (05) : 671 - 683